MDVN

Are Biotech Stocks Nearing Exhaustion… Again? | See It Market

In early April I wrote a piece arguing that biotech stocks – using the iShares Nasdaq Biotech ETF (IBB) as a proxy – looked to be under distribution. At the time the IBB traded at approximately $340. My argument rested on negative divergences in the Shares Outstanding / Price action of the IBB, Block Money Flow trends, an increase in volatility, […]

Medivation Announces Participation at Upcoming Investor Conferences

[Marketwired] – Medivation, Inc. today announced that it will present at the following conferences: moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Strength Seen in Medivation (MDVN): Stock Up 8.5%

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Why Medivation Inc. Shares Roared Higher

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Medivation Q1 Loss Wider Than Expected

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Medivation’s (MDVN) CEO David Hung on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – David T. Hung Thank you, all, for joining us today. We appreciate the opportunity to discuss XTANDI’s performance during the first quarter and the achievements we and our partner, Astellas, have made on … moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, […]